These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25174272)

  • 1. Negative symptom subgroups have different effects on the clinical course of schizophrenia after the first episode: a 24-month follow up study.
    Ergül C; Üçok A
    Eur Psychiatry; 2015 Jan; 30(1):14-9. PubMed ID: 25174272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia.
    Uçok A; Polat A; Genç A; Cakir S; Turan N
    J Psychiatr Res; 2004; 38(2):163-8. PubMed ID: 14757330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study.
    Altamura AC; Bassetti R; Sassella F; Salvadori D; Mundo E
    Schizophr Res; 2001 Oct; 52(1-2):29-36. PubMed ID: 11595389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission after first-episode schizophrenia: results of a long-term follow-up.
    Üçok A; Serbest S; Kandemir PE
    Psychiatry Res; 2011 Aug; 189(1):33-7. PubMed ID: 21196051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-year clinical and functional outcome comparison between first-episode mania with psychotic features and first-episode schizophrenia.
    Chang WC; Lau ES; Chiu SS; Hui CL; Chan SK; Lee EH; Chen EY
    J Affect Disord; 2016 Aug; 200():1-5. PubMed ID: 27107261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One year outcome in first episode schizophrenia. Predictors of relapse.
    Uçok A; Polat A; Cakir S; Genç A
    Eur Arch Psychiatry Clin Neurosci; 2006 Feb; 256(1):37-43. PubMed ID: 16010602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of active psychosis and first-episode psychosis negative symptoms.
    Lyne J; Joober R; Schmitz N; Lepage M; Malla A
    Early Interv Psychiatry; 2017 Feb; 11(1):63-71. PubMed ID: 25582878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative symptom configuration in first episode Schizophrenia: findings from the "Parma Early Psychosis" program.
    Pelizza L; Landi G; Pellegrini C; Quattrone E; Azzali S; Pellegrini P; Leuci E
    Nord J Psychiatry; 2020 May; 74(4):251-258. PubMed ID: 31762390
    [No Abstract]   [Full Text] [Related]  

  • 10. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two and five-factor models of negative symptoms in schizophrenia are differentially associated with trait affect, defeatist performance beliefs, and psychosocial functioning.
    Paul NB; Strauss GP; Gates-Woodyatt JJ; Barchard KA; Allen DN
    Eur Arch Psychiatry Clin Neurosci; 2023 Dec; 273(8):1715-1724. PubMed ID: 36633673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent negative symptoms after first episode schizophrenia: A 2-year follow-up study.
    Üçok A; Ergül C
    Schizophr Res; 2014 Sep; 158(1-3):241-6. PubMed ID: 25107850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom assessment in early psychosis: the use of well-established rating scales in clinical high-risk and recent-onset populations.
    Fulford D; Pearson R; Stuart BK; Fisher M; Mathalon DH; Vinogradov S; Loewy RL
    Psychiatry Res; 2014 Dec; 220(3):1077-83. PubMed ID: 25278477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of specific subscales of the positive and negative symptom scales in older schizophrenia outpatients.
    McAdams LA; Harris MJ; Heaton SC; Bailey A; Fell R; Jeste DV
    Schizophr Res; 1997 Oct; 27(2-3):219-26. PubMed ID: 9416651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Latent Structure of Negative Symptoms in Schizophrenia.
    Strauss GP; Nuñez A; Ahmed AO; Barchard KA; Granholm E; Kirkpatrick B; Gold JM; Allen DN
    JAMA Psychiatry; 2018 Dec; 75(12):1271-1279. PubMed ID: 30208377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of duration of untreated psychosis and premorbid intelligence on cognitive functioning in patients with first-episode schizophrenia.
    Wang MY; Ho NF; Sum MY; Collinson SL; Sim K
    Schizophr Res; 2016 Aug; 175(1-3):97-102. PubMed ID: 27146474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Brief Negative Symptom Scale and its association with functioning.
    Ang MS; Rekhi G; Lee J
    Schizophr Res; 2019 Jun; 208():97-104. PubMed ID: 30987926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year functional outcomes of naturalistically treated patients with schizophrenia.
    Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
    Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: a 2-year longitudinal study.
    Fraguas D; Del Rey-Mejías A; Moreno C; Castro-Fornieles J; Graell M; Otero S; Gonzalez-Pinto A; Moreno D; Baeza I; Martínez-Cengotitabengoa M; Arango C; Parellada M
    Schizophr Res; 2014 Jan; 152(1):130-8. PubMed ID: 24332406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
    Harvey PD; Rabinowitz J; Eerdekens M; Davidson M
    Am J Psychiatry; 2005 Oct; 162(10):1888-95. PubMed ID: 16199835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.